Omar Kujan1, Abdulwahab Abuderman2, Ahmad Zahi Al-Shawaf3. 1. Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, Al-Farabi Colleges, Riyadh, Saudi Arabia; Department of Oral Pathology, Faculty of Dentistry, Hama University, Hama, Syria. 2. College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia; Al-Farabi College of Medicine, Al-Farabi Colleges, Riyadh, Saudi Arabia. 3. Department of Pathology, Faculty of Medicine, Al-Baath University , Homs , Syria.
Abstract
BACKGROUND: Fragile histidine triad (FHIT) is a tumor suppressor gene that is commonly inactivated in human tumors. Interestingly, the normal pattern of FHIT expression is largely unknown. AIM: This study is aimed to characterize the expression of FHIT protein in normal human tissues. MATERIALS AND METHODS: A total of 119 normal human tissue specimens were analyzed for the FHIT expression using immunohistochemistry technique. The inclusion criteria included: normal/inflammatory tissue with no evidence of cellular atypia. RESULTS: All studied specimens were stained positively with FHIT and showed either nuclear or cytoplasmic expression. Interestingly, the pattern of FHIT staining was similar among different specimens from each organ. FHIT is located predominantly in the nucleus, although cytoplasmic staining is also present in some cell types. Oral squamous epithelium, breast ductal epithelium, squamous and tubal metaplastic epithelium of the uterine cervix, esophageal squamous epithelium, salivary glands, and bronchial epithelia all strongly expressed the nuclear protein. In connective tissue, FHIT has shown strong cytoplasmic expression in histocytes including macrophages and dendritic cells, fibroblasts, and myofibroblasts. CONCLUSION: Documentation of the pattern of FHIT expression in normal tissues will contribute to our understanding of the normal function of this protein and to interpretation of potentially altered FHIT expression in human tumors.
BACKGROUND:Fragile histidine triad (FHIT) is a tumor suppressor gene that is commonly inactivated in humantumors. Interestingly, the normal pattern of FHIT expression is largely unknown. AIM: This study is aimed to characterize the expression of FHIT protein in normal human tissues. MATERIALS AND METHODS: A total of 119 normal human tissue specimens were analyzed for the FHIT expression using immunohistochemistry technique. The inclusion criteria included: normal/inflammatory tissue with no evidence of cellular atypia. RESULTS: All studied specimens were stained positively with FHIT and showed either nuclear or cytoplasmic expression. Interestingly, the pattern of FHIT staining was similar among different specimens from each organ. FHIT is located predominantly in the nucleus, although cytoplasmic staining is also present in some cell types. Oral squamous epithelium, breast ductal epithelium, squamous and tubal metaplastic epithelium of the uterine cervix, esophageal squamous epithelium, salivary glands, and bronchial epithelia all strongly expressed the nuclear protein. In connective tissue, FHIT has shown strong cytoplasmic expression in histocytes including macrophages and dendritic cells, fibroblasts, and myofibroblasts. CONCLUSION: Documentation of the pattern of FHIT expression in normal tissues will contribute to our understanding of the normal function of this protein and to interpretation of potentially altered FHIT expression in humantumors.
Entities:
Keywords:
FHIT; human; immunohistochemistry; normal tissues
Authors: Q Yang; G Yoshimura; T Suzuma; T Tamaki; T Umemura; M Nakamura; Y Nakamura; X Wang; I Mori; T Sakurai; K Kakudo Journal: Clin Cancer Res Date: 2001-12 Impact factor: 12.531
Authors: T Druck; P Hadaczek; T B Fu; M Ohta; Z Siprashvili; R Baffa; M Negrini; K Kastury; M L Veronese; D Rosen; J Rothstein; P McCue; M G Cotticelli; H Inoue; C M Croce; K Huebner Journal: Cancer Res Date: 1997-02-01 Impact factor: 12.701
Authors: N S Werner; Z Siprashvili; L Y Fong; G Marquitan; J K Schröder; W Bardenheuer; S Seeber; K Huebner; J Schütte; B Opalka Journal: Cancer Res Date: 2000-06-01 Impact factor: 12.701
Authors: Dimitrios Iliopoulos; Gulnur Guler; Shuang-Yin Han; Teresa Druck; Michelle Ottey; Kelly A McCorkell; Kay Huebner Journal: Cancer Lett Date: 2005-10-12 Impact factor: 8.679
Authors: G Sozzi; U Pastorino; L Moiraghi; E Tagliabue; F Pezzella; C Ghirelli; S Tornielli; L Sard; K Huebner; M A Pierotti; C M Croce; S Pilotti Journal: Cancer Res Date: 1998-11-15 Impact factor: 12.701
Authors: L D Barnes; P N Garrison; Z Siprashvili; A Guranowski; A K Robinson; S W Ingram; C M Croce; M Ohta; K Huebner Journal: Biochemistry Date: 1996-09-10 Impact factor: 3.162
Authors: Svenja Dannewitz Prosseda; Xuefei Tian; Kazuya Kuramoto; Mario Boehm; Deepti Sudheendra; Kazuya Miyagawa; Fan Zhang; David Solow-Cordero; Joshua C Saldivar; Eric D Austin; James E Loyd; Lisa Wheeler; Adam Andruska; Michele Donato; Lingli Wang; Kay Huebner; Ross J Metzger; Purvesh Khatri; Edda Spiekerkoetter Journal: Am J Respir Crit Care Med Date: 2019-01-01 Impact factor: 30.528